ADC Therapeutics (ADCT) Inventory (2021 - 2026)
ADC Therapeutics (ADCT) posted Inventory of $4.8 million for Q1 2026, up 14.15% sequentially from $4.2 million in Q4 2025, and down 72.63% YoY from $17.4 million in Q1 2025.
ADC Therapeutics (ADCT) Inventory (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Inventory for 6 years, with the latest figure at $4.8 million in Q1 2026.
- Quarterly Inventory fell 72.63% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (down 72.63% YoY) and the FY2025 annual result came in at $4.2 million, up 85.87% from the prior year.
- Inventory rose to $4.8 million in Q1 2026 per ADCT's latest filing, from $4.2 million in the prior quarter.
- Over five years, Inventory peaked at $22.7 million in Q3 2023 and troughed at $2.3 million in Q4 2024.
- A 5-year average of $14.3 million and a median of $16.0 million in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2024: Inventory jumped 96.62% in 2022, then sank 86.09% in 2024.
- Over 5 years, Inventory stood at $12.1 million in 2022, then soared by 33.99% to $16.2 million in 2023, then sank by 86.09% to $2.3 million in 2024, then soared by 85.87% to $4.2 million in 2025, then increased by 14.15% to $4.8 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $4.8 million, $4.2 million, and $18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | ADC Therapeutics | 148.95 Mn | -70.15 Mn | 17.14 Mn | 4.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.93 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 4.18 Mn |
| Sep 30, 2025 | 18.04 Mn |
| Jun 30, 2025 | 17.76 Mn |
| Mar 31, 2025 | 17.45 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 16.07 Mn |
| Jun 30, 2024 | 15.19 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 16.18 Mn |
| Sep 30, 2023 | 22.73 Mn |
| Jun 30, 2023 | 19.43 Mn |
| Mar 31, 2023 | 18.25 Mn |
| Dec 31, 2022 | 12.07 Mn |
| Sep 30, 2022 | 15.75 Mn |
| Jun 30, 2022 | 14.65 Mn |
| Mar 31, 2022 | 11.84 Mn |
| Dec 31, 2021 | 11.12 Mn |
| Sep 30, 2021 | 8.01 Mn |